Praziquantel Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 56.8 mg/ml
Reference Brands: Droncit & Generic formulations for this form in EU & US
Category:
Veterinary Product
Praziquantel injection works by disrupting the parasite’s tegument (body surface), causing paralysis and death of trematodes and cestodes. It effectively treats schistosomiasis and tapeworm infections in animals and humans. Benefits include rapid parasite elimination, reduced disease transmission, and improved health outcomes, especially in endemic regions.
Praziquantel injection is available in Injection
and strengths such as 56.8 mg/ml.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Praziquantel injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Praziquantel injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Praziquantel injection is authorized in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality according to GMP standards. In the US, FDA approval requires extensive clinical data and safety evaluation, while in the EU, CE marking certifies conformity with veterinary medicinal product regulations. These products undergo validation, stability testing, and quality audits, with detailed documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring regulatory compliance guarantees access to safe, effective praziquantel formulations for treating parasitic infections in animals worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing